Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

E Sanders-Bush

Showing results (71-80 of 125) with videos related to

Pageof 13
Sort By:
Biochemical Pharmacology|February 1, 1971
p-Chloramphetamine--species differences in the rate of disappearance and the lowering of cerebral serotoninK W Miller, E Sanders-Bush, J V Dingell
The Journal of Pharmacology and Experimental Therapeutics|May 1, 1973
Biogenic amines and narcotic effects. II. Serotonin turnover in the rat after acute and chronic morphine administrationG G Yarbrough, D M Buxbaum, E Sanders-Bush
Molecular Pharmacology|November 19, 2002
Phospholipase D activation by endogenous 5-hydroxytryptamine 2C receptors is mediated by Galpha13 and pertussis toxin-insensitive Gbetagamma subunitsL McGrew, M S S Chang, E Sanders-Bush
Neuroscience|September 11, 2002
Lysergic acid diethylamide-induced Fos expression in rat brain: role of serotonin-2A receptorsP J Gresch, L V Strickland, E Sanders-Bush
Naunyn-Schmiedeberg'S Archives of Pharmacology|September 1, 1983
Acute and chronic effects of serotonin (5HT) antagonists on serotonin binding sitesM A Blackshear, R L Friedman, E Sanders-Bush
The Journal of Pharmacology and Experimental Therapeutics|November 1, 1995
Neurochemical and behavioral evidence that quipazine-ketanserin discrimination is mediated by serotonin2A receptorR L Smith, R J Barrett, E Sanders-Bush
Neuropharmacology|November 1, 1977
Facilitation of Sidman avoidance performance by p-chloroamphetamine: role of biogenic aminesL R Steranka, R J Barrett, E Sanders-Bush
Annals of the New York Academy of Sciences|February 3, 1999
Identification and characterization of RNA editing events within the 5-HT2C receptorC M Niswender, E Sanders-Bush, R B Emeson
Neuropharmacology|November 1, 1986
Adaptive changes in the 5-HT2 binding site after chronic administration of agonists and antagonistsM A Blackshear, L L Martin, E Sanders-Bush
The Journal of Pharmacology and Experimental Therapeutics|March 1, 1984
Discriminative stimulus properties of quipazine: mediation by serotonin2 binding sitesR L Friedman, R J Barrett, E Sanders-Bush
Pageof 13

Showing results (71-80 of 125) with videos related to

Sort By:
Pageof 13
Biochemical Pharmacology|February 1, 1971
p-Chloramphetamine--species differences in the rate of disappearance and the lowering of cerebral serotoninK W Miller, E Sanders-Bush, J V Dingell
The Journal of Pharmacology and Experimental Therapeutics|May 1, 1973
Biogenic amines and narcotic effects. II. Serotonin turnover in the rat after acute and chronic morphine administrationG G Yarbrough, D M Buxbaum, E Sanders-Bush
Molecular Pharmacology|November 19, 2002
Phospholipase D activation by endogenous 5-hydroxytryptamine 2C receptors is mediated by Galpha13 and pertussis toxin-insensitive Gbetagamma subunitsL McGrew, M S S Chang, E Sanders-Bush
Neuroscience|September 11, 2002
Lysergic acid diethylamide-induced Fos expression in rat brain: role of serotonin-2A receptorsP J Gresch, L V Strickland, E Sanders-Bush
Naunyn-Schmiedeberg'S Archives of Pharmacology|September 1, 1983
Acute and chronic effects of serotonin (5HT) antagonists on serotonin binding sitesM A Blackshear, R L Friedman, E Sanders-Bush
The Journal of Pharmacology and Experimental Therapeutics|November 1, 1995
Neurochemical and behavioral evidence that quipazine-ketanserin discrimination is mediated by serotonin2A receptorR L Smith, R J Barrett, E Sanders-Bush
Neuropharmacology|November 1, 1977
Facilitation of Sidman avoidance performance by p-chloroamphetamine: role of biogenic aminesL R Steranka, R J Barrett, E Sanders-Bush
Annals of the New York Academy of Sciences|February 3, 1999
Identification and characterization of RNA editing events within the 5-HT2C receptorC M Niswender, E Sanders-Bush, R B Emeson
Neuropharmacology|November 1, 1986
Adaptive changes in the 5-HT2 binding site after chronic administration of agonists and antagonistsM A Blackshear, L L Martin, E Sanders-Bush
The Journal of Pharmacology and Experimental Therapeutics|March 1, 1984
Discriminative stimulus properties of quipazine: mediation by serotonin2 binding sitesR L Friedman, R J Barrett, E Sanders-Bush
Pageof 13